Lista de obras - Attilio Orazi - Dominio Público Uruguay

A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia.

artículo científico publicado en 2016

A Lucky Mistake: The Splenic Glands of Marcello Malpighi.

artículo científico publicado en 2017

A multimodality work-up of patients with Hypereosinophilia

artículo científico publicado en 2018

A rare case of acute myeloid leukemia with der(1)t(1;19)(p13;p13.1)

artículo científico publicado en 2019

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

artículo científico publicado en 2015

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

artículo científico publicado en 2015

Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.

artículo científico publicado en 2017

Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q) ⬇️

artículo científico publicado el 17 de septiembre de 2012

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

artículo científico publicado en 2013

Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group

artículo científico publicado en 2018

Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis

scientific article published on 02 September 2019

Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology

artículo científico publicado en 2006

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.

artículo científico publicado en 2018

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

artículo científico publicado en 2016

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

artículo científico publicado en 2014

Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group

scientific article published on 18 April 2019

Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma ⬇️

artículo científico publicado el 17 de septiembre de 2010

Comments on pre-fibrotic myelofibrosis and how should it be managed

scientific article published on 07 March 2019

Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection ⬇️

artículo científico publicado el 1 de enero de 1998

Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases

artículo científico publicado en 2015

Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms

artículo científico publicado en 2018

Distinct morphophenotypic features of chronic B-cell leukaemias identified with CDlc and CD23 antibodies ⬇️

artículo científico publicado el 1 de julio de 1991

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2015

Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma

artículo científico publicado en 2014

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.

artículo científico publicado en 2017

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

artículo científico publicado en 2015

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis ⬇️

artículo científico publicado el 30 de julio de 2013

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

artículo científico publicado en 2016

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

article

Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016

artículo científico publicado en 2018

Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases

artículo científico publicado en 2007

How I investigate chronic myelomonocytic leukemia

artículo científico publicado en 2019

Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma

artículo científico publicado en 2014

Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.

artículo científico publicado en 2017

Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology.

artículo científico publicado en 2016

JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group

scientific article published on 16 May 2018

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

artículo científico publicado en 2016

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

artículo científico publicado en 2013

Mastocytosis and related disorders ⬇️

artículo científico publicado el 1 de febrero de 2012

Mesocaval shunt inhibits primary and metastatic hepatoma growth and enhances apoptosis ⬇️

artículo científico publicado el 1 de julio de 1998

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

artículo científico publicado en 2014

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

artículo científico publicado en 2012

Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis

artículo científico publicado en 2017

Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity

scientific article published on 01 June 1991

Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1α, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer ⬇️

artículo científico publicado el 1 de marzo de 1998

Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia.

artículo científico publicado en 2017

Myeloid sarcoma with t(11;19)(q23;p13.3) (MLL‐ELL) in the uterine cervix ⬇️

artículo científico publicado el 19 de abril de 2011

Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates

artículo científico publicado en 2016

Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.

artículo científico publicado en 2018

Nuclear factor-erythroid 2, nerve growth factor receptor, and CD34-microvessel density are differentially expressed in primary myelofibrosis, polycythemia vera, and essential thrombocythemia

artículo científico publicado en 2015

Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia

artículo científico publicado en 2017

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

artículo científico publicado en 2012

Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow : Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Gr

artículo científico publicado en 2017

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

artículo científico publicado en 2014

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

artículo científico publicado en 2014

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

artículo científico publicado en 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

artículo científico publicado en 2015

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

artículo científico publicado en 2015

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

scientific article published on 02 May 2019

Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant

artículo científico publicado en 2016

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

artículo científico publicado en 2013

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

artículo científico publicado en 2016

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

artículo científico publicado en 2013

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.

artículo científico publicado en 2016

Terminal Deoxynucleotidyl Transferase Staining in acute Leukemia and Normal Bone Marrow in Routinely Processed Paraffin Sections ⬇️

artículo científico publicado el 1 de noviembre de 1994

The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review

scientific article published on 04 December 2019

The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis

artículo científico publicado en 2017

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations

artículo científico publicado en 2016

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations

scientific article published on 01 July 2017

Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow

artículo científico publicado en 2004

Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study

artículo científico publicado en 2018

Update on the pathologic diagnosis of chronic myelomonocytic leukemia

scientific article published on 05 February 2019

Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.

artículo científico publicado en 2008

World Health Organization Classification of Myelodysplastic Syndromes ⬇️

artículo científico publicado el 1 de enero de 2012

p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function

artículo científico publicado en 2016

Lista de obras de Attilio Orazi

A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia.

A Lucky Mistake: The Splenic Glands of Marcello Malpighi.

A multimodality work-up of patients with Hypereosinophilia

A rare case of acute myeloid leukemia with der(1)t(1;19)(p13;p13.1)

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.

Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q) ⬇️

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group

Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis

Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology

Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma.

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

Clinical implications of phosphorylated STAT3 expression in De Novo diffuse large B-cell lymphoma

Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group

Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma ⬇️

Comments on pre-fibrotic myelofibrosis and how should it be managed

Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection ⬇️

Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases

Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms

Distinct morphophenotypic features of chronic B-cell leukaemias identified with CDlc and CD23 antibodies ⬇️

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma

European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia.

Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions

Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis ⬇️

Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study

Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016

Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases

How I investigate chronic myelomonocytic leukemia

Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma

Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version.

Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology.

JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group

Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Pr

Mastocytosis and related disorders ⬇️

Mesocaval shunt inhibits primary and metastatic hepatoma growth and enhances apoptosis ⬇️

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis

Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico-pathological entity

Myeloid Progenitor Cell Proliferation and Mobilization Effects of BB10010, a Genetically Engineered Variant of Human Macrophage Inflammatory Protein-1α, in a Phase I Clinical Trial in Patients with Relapsed/Refractory Breast Cancer ⬇️

Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia.

Myeloid sarcoma with t(11;19)(q23;p13.3) (MLL‐ELL) in the uterine cervix ⬇️

Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates

Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.

Nuclear factor-erythroid 2, nerve growth factor receptor, and CD34-microvessel density are differentially expressed in primary myelofibrosis, polycythemia vera, and essential thrombocythemia

Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow : Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Gr

Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries

Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma.

Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.

Terminal Deoxynucleotidyl Transferase Staining in acute Leukemia and Normal Bone Marrow in Routinely Processed Paraffin Sections ⬇️

The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review

The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations

Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow

Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study

Update on the pathologic diagnosis of chronic myelomonocytic leukemia

Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.

World Health Organization Classification of Myelodysplastic Syndromes ⬇️

p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function